98%
921
2 minutes
20
Introduction: Preterm birth is associated with poor expiratory airflow, but spirometry phenotypes are not well-described.
Objectives: To characterise abnormal spirometry phenotypes at age 8 years in children born either extremely preterm (EP; <28 weeks' gestation) or extremely low birth weight (ELBW; <1000 g birth weight), and to describe the early-life (perinatal and early growth) variables associated with each phenotype.
Methods: Participants comprised survivors born EP/ELBW in Victoria, Australia, in three eras (1991-1992, 1997 and 2005) and contemporaneous term-born controls with spirometry data at 8 years. Abnormal spirometry phenotypes included: prematurity-associated obstructive lung disease (POLD), prematurity-associated preserved ratio of impaired spirometry (pPRISm) and prematurity-associated dysanapsis (pDysanapsis). Lung volumes measured by plethysmography and early-life variables were compared between each abnormal and the normal spirometry phenotype.
Results: Overall, 29% (156/544) of children born EP/ELBW had an abnormal spirometry phenotype compared with 9% (47/524) term-born controls (OR 4.06, 95% CI 2.85 to 5.79; p<0.001). Compared with children born EP/ELBW with normal spirometry (71%), children born EP/ELBW with pPRISm (11%) had reduced total lung volume. Both POLD (8%) and pPRISm phenotypes showed evidence of air trapping. Bronchopulmonary dysplasia was associated with both POLD and pPRISm. Lower gestational age and poorer weight gain between birth and 2 years were associated with pPRISm. No early life variables were associated with pDysanapsis (9%).
Conclusion: Over one-quarter of children born EP/ELBW have abnormal spirometry phenotypes. Abnormal spirometry phenotypes differ in their associations with perinatal or early growth variables.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/thorax-2024-222602 | DOI Listing |
ERJ Open Res
September 2025
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Background: Airway obstruction is a characteristic spirometric finding in asthma but the clinical significance of other abnormal spirometric patterns is less well described. We aimed to explore pre- and post-bronchodilator (BD) prevalences and clinical characteristics of preserved ratio impaired spirometry (PRISm), dysanapsis and airflow obstruction with low forced expiratory volume in 1 s (FEV) in children diagnosed with asthma.
Methods: We extracted specialist care data (clinical and spirometry) from the Swedish National Airway Register (n=3301, age 5-17 years).
Pulm Ther
September 2025
Department of Pulmonary Function Test, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
Introduction: Preserved ratio impaired spirometry (PRISm) is an important phenotype of pulmonary function in clinical and public health practice. It is possible for some patients to have chronic obstructive pulmonary disease (COPD) at an early stage. At present there is little research on the association of PRISm with type 2 (T2) inflammation biomarkers.
View Article and Find Full Text PDFJ Cyst Fibros
August 2025
Department of Development and Regeneration, Woman and Child Unit, CF Research Lab, KU Leuven, Leuven, Belgium; Department of Pediatrics, Pediatric Pulmonology, University Hospital Leuven, Leuven, Belgium.
Background: Patient-derived intestinal organoids (PDIOs) are an in vitro tool used to predict clinical responses to CFTR modulators in people with cystic fibrosis (pwCF). Although strong genotype-based correlations have been observed, individual responses among F508del homozygous pwCF remain variable. We aimed to assess this correlation specifically within this group.
View Article and Find Full Text PDFBMC Med
August 2025
Department of General Practice, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Background: Emerging epidemiological evidence implicates pulmonary dysfunction in cardiovascular pathogenesis, yet its arrhythmogenic potential remains poorly defined.
Objectives: We aimed to assess the link between ventilatory parameters, pulmonary disease phenotypes and risk of incident arrhythmias across diverse populations.
Methods: We analyzed data from 17,684 adults in two prospective cohort studies-the Atherosclerosis Risk in Communities (ARIC; n = 12,929) and Cardiovascular Health Study (CHS; n = 4,755).
J Cachexia Sarcopenia Muscle
August 2025
Barts Heart Centre, St Bartholomew's Hospital, Barts NHS Trust, London, UK.
Background: As a major systemic insult, cardiac surgery can lead to significant muscle loss, which increases the time to recovery as well as being correlated with mortality. Highly variable loss of muscle mass (0%-40% rectus femoris cross-sectional area [RFcsa]) and strength in the week after surgery has aided understanding of mechanisms of sarcopenia after acute illness. To include muscle recovery, patients' muscle phenotype beyond the first week after surgery and up to their return as outpatients was studied and correlated with protein and metabolomic markers.
View Article and Find Full Text PDF